What if Oprah Knew About Fractyl Health?
People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick?
People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick?
Fractyl Health will use the IPO proceeds for pivotal testing of a medical device and surgical procedure intended to address root causes of diabetes and obesity. The Fractyl pipeline also includes a gene therapy for these conditions.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.